Regulatory Questions in the Development of Blood Stem Cell Products for Regenerative Therapy

Le résumé fourni par la source

Blood stem cells have been used for decades to regenerate the bone marrow in patients with degenerative disorders of the blood system. Recent studies demonstrating the potential of blood stem cells to mediate the regeneration of tissues other than blood provide encouragement for their broader therapeutic use. Regulatory oversight plays a key role in ensuring the safety, quality and effectiveness of blood stem cells for regenerative therapy. This chapter outlines the current federal regulations governing therapeutic use of blood stem cells from a Canadian perspective. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.